Sofosbuvir, velpatasvir and voxilaprevir combination therapy for treating patients with hepatitis C virus infection.

Summers, B B

Sofosbuvir, velpatasvir and voxilaprevir combination therapy for treating patients with hepatitis C virus infection. [electronic resource] - Drugs of today (Barcelona, Spain : 1998) Apr 2018 - 255-268 p. digital

Publication Type: Journal Article; Review

1699-3993

10.1358/dot.2018.54.4.2788017 doi


Aminoisobutyric Acids
Antiviral Agents--adverse effects
Carbamates--adverse effects
Cyclopropanes
Drug Combinations
Hepacivirus--drug effects
Hepatitis C--diagnosis
Heterocyclic Compounds, 4 or More Rings--adverse effects
Humans
Lactams, Macrocyclic
Leucine--analogs & derivatives
Macrocyclic Compounds--adverse effects
Proline--analogs & derivatives
Quinoxalines
Sofosbuvir--adverse effects
Sulfonamides--adverse effects
Treatment Outcome